ANTI-S100A7 ANTIBODIES FOR THE TREATMENT AND DIAGNOSIS OF CANCER

The present invention relates to the use of antibodies against S100A7 protein for the prevention and/or treatment of cancer or a disease associated to an undesired angiogenesis or a disease associated with inflammation; and to methods and kits for diagnosing and determining the prognostic of said di...

Full description

Saved in:
Bibliographic Details
Main Authors FRANCESC MITJANS PRAT, ROSA Mª HERVAS VILLEGAS, JOSÉ LUIS HERNÁNDEZ MÍGUEZ, SHEILA DAKHEL PLAZA, JOSEP MARIA MARTÍNEZ ESCOLÀ, MARC MASA ÁLVAREZ, ANTONIO COLL MANZANO, LOURDES TATIANA ROQUE NAVARRO, LAURA PADILLA GARCÍA, RAMON MESSEGUER PEYPOCH, LAURA BARBERÀ FERRANDO, CARME CALVIS CALPE, JAUME ADAN PLANA, MANUEL RIVAS CAÑAS
Format Patent
LanguageEnglish
Portuguese
Published 19.09.2017
Subjects
CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the use of antibodies against S100A7 protein for the prevention and/or treatment of cancer or a disease associated to an undesired angiogenesis or a disease associated with inflammation; and to methods and kits for diagnosing and determining the prognostic of said diseases in vitro and in vivo by means of detecting levels of S100A7 in a biofluid, preferably with an antibody. The invention also relates to specific anti-S100A7 monoclonal antibodies, hybridoma cell lines producing them and method for obtaining them, as well as pharmaceutical compositions and conjugates containing them.
Bibliography:Application Number: PT20140723729T